These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2899632)

  • 1. Particulate contamination in solutions of antibiotics packed as dry powders in vials.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1988 May; 40(5):358-9. PubMed ID: 2899632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate contamination in ampoules.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):53-5. PubMed ID: 2858528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particles in small volume injections.
    Taylor SA; Spence J
    J Pharm Pharmacol; 1983 Dec; 35(12):769-73. PubMed ID: 6141237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of particulate contamination in ampoules using a light blockage particle analyser.
    Alexander DM; Veltman AM
    J Pharm Pharmacol; 1985 Jan; 37(1):13-6. PubMed ID: 2858521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate contamination of Australian ampoules.
    Gillies IR; Thiel WJ; Oppenheim RC
    J Pharm Pharmacol; 1986 Feb; 38(2):87-92. PubMed ID: 2870168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on particulate contamination of commercial antibiotics.
    Masuda JY; Beckerman JH
    Am J Hosp Pharm; 1973 Apr; 30(4):297. PubMed ID: 4697651
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particulate contamination in plastic ampoules.
    Oppenheim RC; Gillies IR
    J Pharm Pharmacol; 1986 May; 38(5):344-7. PubMed ID: 2872309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of particulate matter in small volume antibiotic injections].
    Niizeki M; Tanno K
    Jpn J Antibiot; 1989 Mar; 42(3):567-72. PubMed ID: 2746842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of official instrumental methods for the determination of particulate matter contamination in large volume parenteral solutions.
    Montanari L; Pavanetto F; Conti B; Ponci R; Grassi M
    J Pharm Pharmacol; 1986 Nov; 38(11):785-90. PubMed ID: 2879006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate contamination of sterile syringes and needles.
    Taylor SA
    J Pharm Pharmacol; 1982 Aug; 34(8):493-5. PubMed ID: 6126558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foreign particles in powder ampoules and vials.
    Ernerot L; Mellström G
    Acta Pharm Suec; 1969 Apr; 6(2):283-6. PubMed ID: 5824843
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate contamination in selected parenteral drugs.
    Longe RL
    Can Anaesth Soc J; 1980 Jan; 27(1):62-4. PubMed ID: 7353193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of particulate contamination in intravenous administration sets.
    Di Paolo ER; Hirschi B; Pannatier A
    Pharm Weekbl Sci; 1990 Oct; 12(5):190-5. PubMed ID: 2255588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate contamination of lyophilized amphotericin B preparation during reconstitution process.
    Sendo T; Hirakawa M; Makino K; Nakashima K; Kataoka Y; Oishi R
    J Clin Pharm Ther; 2001 Apr; 26(2):87-91. PubMed ID: 11350530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.